Journal of Oncology
Volume 2010 (2010), Article ID 917356, 7 pages
doi:10.1155/2010/917356
Clinical Study

Outcome of Combined Hepatocellular and Cholangiocarcinoma of the Liver

Jue Wang,1 Fenwei Wang,2 and Anne Kessinger1

1Section of Oncology-Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198-7680, USA
2Department of Internal Medicine, Creighton University, Omaha, NE 68131, USA

Received 27 March 2010; Revised 12 June 2010; Accepted 14 July 2010

Academic Editor: Jörg Kleeff

Copyright © 2010 Jue Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Allen and J. A. Lisa, “Combined liver cell and bile duct carcinoma,” American Journal of Pathology, vol. 25, pp. 647–655, 1949.
  2. Z. D. Goodman, K. G. Ishak, and J. M. Langloss, “Combined hepatocellular cholangiocarcinoma. A histologic and immunohistochemical study,” Cancer, vol. 55, no. 1, pp. 124–135, 1985. View at Scopus
  3. H. Kim, C. Park, K.-H. Han, J. Choi, Y. B. Kim, J. K. Kim, and Y. N. Park, “Primary liver carcinoma of intermediate (hepatocyte-cholangiocyte) phenotype,” Journal of Hepatology, vol. 40, no. 2, pp. 298–304, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Zhang, X.-P. Chen, W. Zhang, H.-H. Dong, S. Xiang, W.-G. Zhang, and B.-X. Zhang, “Combined hepatocellular cholangiocarcinoma originating from hepatic progenitor cells: immunohistochemical and double-fluorescence immunostaining evidence,” Histopathology, vol. 52, no. 2, pp. 224–232, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. J. Taguchi, O. Nakashima, M. Tanaka, T. Hisaka, T. Takazawa, and M. Kojiro, “A Clinicopathological study on combined hepatocellular and cholangiocarcinoma,” Journal of Gastroenterology and Hepatology, vol. 11, no. 8, pp. 758–764, 1996. View at Scopus
  6. T. Maeda, E. Adachi, K. Kajiyama, K. Sugimachi, and M. Tsuneyoshi, “Combined hepatocellular and cholangiocarcinoma: proposed criteria according to cytokeratin expression and analysis of clinicopathologic features,” Human Pathology, vol. 26, no. 9, pp. 956–964, 1995. View at Scopus
  7. Y. Imai, H. Oda, M. Arai, S. Shimizu, Y. Nakatsuru, T. Inoue, and T. Ishikawa, “Mutational analysis of the p53 and K-ras genes and allelotype study of the Rb-1 gene for investigating the pathogenesis of combined hepatocellular-cholangiocellular carcinomas,” Japanese Journal of Cancer Research, vol. 87, no. 10, pp. 1056–1062, 1996. View at Scopus
  8. T. Wakasa, K. Wakasa, and K. Wakasa, “A histopathological study on combined hepatocellular and cholangiocarcinoma: cholangiocarcinoma component is originated from hepatocellular carcinoma,” Hepatogastroenterology, vol. 54, no. 74, pp. 508–513, 2007. View at Scopus
  9. H.-Q. Zuo, L.-N. Yan, Y. Zeng, J.-Y. Yang, H.-Z. Luo, J.-W. Liu, and L.-X. Zhou, “Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma,” Hepatobiliary and Pancreatic Diseases International, vol. 6, no. 2, pp. 161–165, 2007. View at Scopus
  10. S. Chantajitr, C. Wilasrusmee, P. Lertsitichai, and N. Phromsopha, “Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population,” Journal of Hepato-Biliary-Pancreatic Surgery, vol. 13, no. 6, pp. 537–542, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. W.-S. Lee, K.-W. Lee, J.-S. Heo, S.-J. Kim, S.-H. Choi, Y.-I. Kim, and J.-W. Joh, “Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma,” Surgery Today, vol. 36, no. 10, pp. 892–897, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. J. Taguchi, O. Nakashima, M. Tanaka, T. Hisaka, T. Takazawa, and M. Kojiro, “A Clinicopathological study on combined hepatocellular and cholangiocarcinoma,” Journal of Gastroenterology and Hepatology, vol. 11, no. 8, pp. 758–764, 1996. View at Scopus
  13. I. O. L. Ng, T. W. H. Shek, J. Nicholls, and L. T. Ma, “Combined hepatocellular-cholangiocarcinoma: a clinicopathological study,” Journal of Gastroenterology and Hepatology, vol. 13, no. 1, pp. 34–40, 1998. View at Scopus
  14. R. T. Poon, S. T. Fan, and S. T. Fan, “Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database,” Annals of Surgery, vol. 240, no. 4, pp. 698–708, 2004. View at Publisher · View at Google Scholar
  15. W. R. Jarnagin, S. Weber, and S. Weber, “Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors,” Cancer, vol. 94, no. 7, pp. 2040–2046, 2002. View at Publisher · View at Google Scholar · View at PubMed
  16. K. C. Koh, H. Lee, and H. Lee, “Clinicopathologic features and prognosis of combined hepatocellular cholangiocarcinoma,” American Journal of Surgery, vol. 189, no. 1, pp. 120–125, 2005. View at Publisher · View at Google Scholar · View at PubMed
  17. T. Uenishi, K. Hirohashi, and K. Hirohashi, “Surgically treated cases of mixed hepatocellular carcinoma and cholangiocarcinoma,” Hepatogastroenterology, vol. 49, no. 46, pp. 1083–1086, 2002.
  18. C.-L. Liu, S.-T. Fan, C.-M. Lo, I. O.-L. Ng, C.-M. Lam, R. T.-P. Poon, and J. Wong, “Hepatic resection for combined hepatocellular and cholangiocarcinoma,” Archives of Surgery, vol. 138, no. 1, pp. 86–90, 2003.
  19. L. McCormack, H. Petrowsky, and P.-A. Clavien, “Surgical therapy of hepatocellular carcinoma,” European Journal of Gastroenterology and Hepatology, vol. 17, no. 5, pp. 497–503, 2005. View at Publisher · View at Google Scholar
  20. Surveillance, Epidemiology, and End Results (SEER) Program, Public-Use Data (1973–2004), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, April 2002, http://www.seer.cancer.gov/about/expansion.html.
  21. “SEER Summary Staging Manual,” 2000, http://seer.cancer.gov/tools/ssm/.
  22. Y. Shiratori, H. Yoshida, and M. Omata, “Management of hepatocellular carcinoma: advances in diagnosis, treatment and prevention,” Expert Review of Anticancer Therapy, vol. 1, no. 2, pp. 277–290, 2001.
  23. C. J. Sonnenday, J. B. Dimick, R. D. Schulick, and M. A. Choti, “Racial and geographic disparities in the utilization of surgical therapy for hepatocellular carcinoma,” Journal of Gastrointestinal Surgery, vol. 11, no. 12, pp. 1636–1646, 2007. View at Publisher · View at Google Scholar · View at PubMed
  24. D. Sloane, H. Chen, and C. Howell, “Racial disparity in primary hepatocellular carcinoma: tumor stage at presentation, surgical treatment and survival,” Journal of the National Medical Association, vol. 98, no. 12, pp. 1934–1939, 2006.
  25. Y. Fukukura, J. Taguchi, O. Nakashima, Y. Wada, and M. Kojiro, “Combined hepatocellular and cholangiocarcinoma: correlation between CT findings and clinicopathological features,” Journal of Computer Assisted Tomography, vol. 21, no. 1, pp. 52–58, 1997. View at Publisher · View at Google Scholar
  26. S. Phongkitkarun, T. Srisuwan, P. Sornmayura, and J. Jatchavala, “Combined hepatocellular and cholangiocarcinoma: CT Findings with emphasis on multiphasic helical CT,” Journal of the Medical Association of Thailand, vol. 90, no. 1, pp. 113–120, 2007.
  27. J. Bruix, A. J. Hessheimer, A. Forner, L. Boix, R. Vilana, and J. M. Llovet, “New aspects of diagnosis and therapy of hepatocellular carcinoma,” Oncogene, vol. 25, no. 27, pp. 3848–3856, 2006. View at Publisher · View at Google Scholar · View at PubMed
  28. S.-T. Fan, C.-M. Lo, C.-L. Liu, C.-M. Lam, W.-K. Yuen, C. Yeung, and J. Wong, “Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths,” Annals of Surgery, vol. 229, no. 3, pp. 322–330, 1999.
  29. S. Virani, J. S. Michaelson, and J. S. Michaelson, “Morbidity and mortality after liver resection: results of the patient safety in surgery study,” Journal of the American College of Surgeons, vol. 204, no. 6, pp. 1284–1292, 2007. View at Publisher · View at Google Scholar · View at PubMed
  30. V. Mazzaferro, E. Regalia, and E. Regalia, “Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis,” New England Journal of Medicine, vol. 334, no. 11, pp. 693–699, 1996. View at Publisher · View at Google Scholar · View at PubMed
  31. C. G. Meyer, I. Penn, and L. James, “Liver transplantation for cholangiocarcinoma: results in 207 patients,” Transplantation, vol. 69, no. 8, pp. 1633–1637, 2000.
  32. A. C.-Y. Chan, C. M. Lo, I. O.-L. Ng, and S. T. Fan, “Liver transplantation for combined hepatocellular cholangiocarcinoma,” Asian Journal of Surgery, vol. 30, no. 2, pp. 143–146, 2007.
  33. J. M. Llovet, M. I. Real, X. Montana, et al., “Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial,” The Lancet, vol. 359, no. 9319, pp. 1734–1739, 2002. View at Publisher · View at Google Scholar · View at PubMed
  34. S. Okada, “Local ablation therapy for hepatocellular carcinoma,” Seminars in Liver Disease, vol. 19, no. 3, pp. 323–328, 1999.
  35. E. A. Dick, S. D. Taylor-Robinson, H. C. Thomas, and W. M. W. Gedroyc, “Ablative therapy for liver tumours,” Gut, vol. 50, no. 5, pp. 733–739, 2002. View at Publisher · View at Google Scholar
  36. W. T. Kassahun and J. Hauss, “Management of combined hepatocellular and cholangiocarcinoma,” International Journal of Clinical Practice, vol. 62, no. 8, pp. 1271–1278, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus